Posted on

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification

STEP Young data show 40.4% of children treated with semaglutide and lifestyle modification were no longer classified as having obesity.

Go to Source

By sf-admin